References
- World Health Organization (WHO). Community control of hereditary anaemias: Memorandum from a WHO meeting. Bull World Health Organ. 1983;61(1):63–80
- Weatherall DJ, Clegg JB. Inherited haemoglobin disorders: An increasing global health problem. Bull World Health Organ. 2001;79(8):704–712
- Filosa A, Vitrano A, Rigano P, et al. Long-term treatment with deferiprone enhances left ventricular ejection function when compared to deferoxamine in patients with thalassemia major. Blood Cells Mol Dis. 2013;51(2):85–88
- Borgna-Pignatti C, Rugolotto S, De Stefano P, et al. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica. 2004;89(10):1187–1193
- Galanello R, Origa R. β-Thalassemia. Orphanet J Rare Dis. 2010;5:11. doi: 10.1186/1750-1172-5-11
- Amin A, Jalali S, Amin R, et al. Evaluation of the serum levels of immunoglobulin and complement factors in β-thalassemia major patients in Southern Iran. Iran J Immunol. 2005;2(4):220–225
- Ghanem A. Immunological status in thalassemia. Alexandria, Egypt: Alexandria University, 1992
- Kim DD, Song WC. Membrane complement regulatory proteins. Clin Immunol. 2006;118(2–3):127–136
- Obaid JMAS, Abo El-Nazar SY, Ghanem AM, et al. Expression of CD55 on red blood cells of β-thalassemia patients. Hemoglobin. 2014;38(5):339–344
- Alegretti AP, Mucenic M, Breno JCT, et al. The role of CD55/CD59 complement regulatory proteins on peripheral blood cells of systemic lupus erythematosus patients. Rev Bras Rheumatol. 2009;49(3):281–287
- Röth A, Dührsen U. Paroxysmal nocturnal hemoglobinuria. Dtsch Arztebl. 2007;104(4):A192–A197
- Shah N, Mishra A, Chauhan D, et al. Study on effectiveness of transfusion program in thalassemia major patients receiving multiple blood transfusions at a transfusion centre in Western India. Asian J Transfus Sci. 2010;4(2):94–98
- Ragab LA, Hamdy MM, Shaheen IA, Yassin RN. Blood transfusion among thalassemia patients: A single Egyptian center experience. Asian J Transfus Sci. 2013;7(1):33–36
- Madan N, Sikka M, Sharma S, et al. Red cell indices and discriminant functions in the detection of β-thalassaemia trait in a population with high prevalence of iron deficiency anaemia. Indian J Pathol Microbiol. 1999;42(1):55–61
- Lau EH, He XQ, Lee CK, Wu JT. Predicting future blood demand from thalassemia major patients in Hong Kong. PLoS One. 2013;8(12):e81846. doi: 10.1371/journal.pone.0081846. eCollection 2013
- Harris CL, Pettigrew DM, Lea SM, Morgan BP. Decay-accelerating factor must bind both components of the complement alternative pathway C3 convertase to mediate efficient decay. J Immunol. 2007;178(1):352–359
- Owen JPJ, Stranford SA, Jones PP, Eds. Kuby Immunology, 7th ed. New York, NY: W.H. Freeman. 2009:209
- Parker C, Omine M, Richards S, et al. Diagnosis and management of paroxysmal nocturnal hemoglobinuria. Blood. 2005;106(12):3699–3709
- Mazumdar B, Kim H, Meyer K, et al. Hepatitis C virus infection upregulates CD55 expression on the hepatocyte surface and promotes association with virus particles. J Virol. 2013;87(14):7902–7910
- Alegretti AP, Mucenic T, Merzoni J, et al. Expression of CD55 and CD59 on peripheral blood cells from systemic lupus erythematosus (SLE) patients. Cell Immunol. 2010;265(2):127–132
- Gwamaka M, Fried M, Domingo G, Duffy PE. Early and extensive CD55 loss from red blood cells supports a causal role in malarial anaemia. Malar J. 2011;10:386. doi: 10.1186/1475-2875-10-386
- Pourazar A, Andalib AR, Oreizy F, et al. A flowcytometry study of CD55 and CD59 expression on erythrocytes in rheumatoid arthritis patients. Iranian J Immunol. 2005;2(2):91–96